Introduction
Neurotuberculosis is a common neurological disorder in developing countries. Among all patients of neurotuberculosis, tubercular meningitis is an important manifestation with high morbidity and mortality 4 . Diagnosis is based on clinical features, C.S.F. changes, & imaging. Polymerage chain reaction shows promise for the future. Appropriate chemotherapeutic agents should be given as early as possible. Role of corticosteroids is controversial but should be administered to all patients presenting in stage III 1 . Surgical procedures are directed only when, hydrocephalus, focal lesions, intracranial tuberculomas, and tuberculous abscesses, are located in cerebral or cerebellar hemispheres, uncommonly in brainstem and very rarely in spinal cord but usually surgical intervention is not required. Almost all patients respond well to medical management (ATT, ATT+Corticosteroids). The patients who received ATT+steroids (oral steroids in tapering doses over a period of 4-6 weeks) showed early symptomatic & therapeutic response & the recovery was smooth over period 1 
.
Increasing prevalence of HIV infection, in today's scenerio, in underdeveloped countries contributes to prevelance of Neurotuberculosis 4 .Other important risk factors includes over-crowding of urban population, poor nutritional status, appearance of drug-resistant strains of tuberculosis, ineffective tuberculosis control programmes, and increase in migration from countries where tuberculosis is prevalent to the developed world.
Material and Method
The present study was carried out on 50 cases 4. Adenosine Deaminase (ADA): ADA is an important enzyme in purine metabolism; irreversibly deaminates adenosine to inosine. It is associated with lymphocytic proliferation and differentiation and is a marker of cell mediated immunity. Two isoforms ADA1 and ADA2 are known. ADA2 is the major contributor to the total ADA seen in TBM. Sensitivities andspecificities range from 73-100% and 71-99% respectively. 4 .
Other non specific indicators of tuberculosis were discarded (like bromide partition test)
Clearcut diagnosed and primarily treated cases were selected for the study.All the patients admitted for any reason to ICU were NOT taken in this study.
RESULTS
Out of the 30 control individuals,the patients neighter needed ATT, or ATT with steroids or steroids for any detectable reason. And these patients responded well to the specific treatment they were given for their respective illnesses other than tuberculosis.
In patients with neurotuberculosis, male & female patients didn't show any difference in treatment variability, with two different groups. One with ATT alone & another with ATT + steroids in routine standard doses (Dexamethasone 0.4mg/kg body weight IV during hospitalisation, followed by Prednisolone orally in doses of 1mg/Kg body weight, in tapering doses over a period of 4-6 weeks).
The survival rate was 100%, & none patient required ICU management.These patients were hospitalised for fairly enough time for symptomatic relief, and then followed initially fornightly,then monthly till end of therapy, and finally all relevent investigation were performed to observe a satisfactory outcome before stopping their treatment & allowing them to live normal routine. TNF alpha play a important role in pathogenesis and leads to altered blood brain barrier permeability and CSF leukocytosis. The use of corticosteroids as adjunctive therapy in t/t of CNS tuberculosis begins as early as 1950 1 . It was proposed that steroids causes reduction of inflammation within subarachnoid space. It causes modulation of the local production of proinflammatory cytokines and chemokines by microglial cells. But the exact mechanism is not clear.
Adults (>14 years) should start treatment with dexamethasone 0.4 mg/kg/24 hr IV during hospitalization, followed by prednisolone 1mg/kg bodyweight/day orally (after meals)with a tapering course over 6-8 weeks. High CSF ADA activity has been reported in patient with lymphoma, malaria, brucellosis, pyogenic meningitis and cerebral lymphoma. The Infectious Disease Society of America, CDC and ATC recommend the use of Steroid therapy as an adjunctive therapy with standard anti tuberculosis therapy in CNS affection with mycobacterium 
